Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity

Chengsong Yan,Lin Zheng,Shutan Jiang,Haochen Yang,Jun Guo,Tongzhou Li,Haosong Zhang,Yibing Bai,Yu Lou,Qi Zhang,Tingbo Liang,Wolfgang Schamel,Haopeng Wang,Weiwei Yang,Guangchuan Wang,Bao-Liang Song,Chenqi Xu,Lu-yi Jiang,Zheng-jiang Zhu

DOI: https://doi.org/10.1016/j.ccell.2023.04.016

IF: 50.3

2023-05-01

Cancer Cell

Abstract:The concept of targeting cholesterol metabolism to treat cancer has been widely tested in clinics, but the benefits are modest, calling for a complete understanding of cholesterol metabolism in intratumoral cells. We analyze the cholesterol atlas in the tumor microenvironment and find that intratumoral T cells have cholesterol deficiency, while immunosuppressive myeloid cells and tumor cells display cholesterol abundance. Low cholesterol levels inhibit T cell proliferation and cause autophagy-mediated apoptosis, particularly for cytotoxic T cells. In the tumor microenvironment, oxysterols mediate reciprocal alterations in the LXR and SREBP2 pathways to cause cholesterol deficiency of T cells, subsequently leading to aberrant metabolic and signaling pathways that drive T cell exhaustion/dysfunction. LXRβ depletion in chimeric antigen receptor T (CAR-T) cells leads to improved antitumor function against solid tumors. Since T cell cholesterol metabolism and oxysterols are generally linked to other diseases, the new mechanism and cholesterol-normalization strategy might have potential applications elsewhere.

oncology,cell biology